Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Global Compliance
Names of Lobbyists
Most Frequently Disclosed Lobbying Issues
- Labor, Antitrust & Workplace,
RegulationsMentioned in 13 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Global Compliance" in public comments on proposed federal regulations.
Mentions in Document Text
View all mentions data for Global Compliance
- Toggle 3 FDA Section 301. Foreign Supplier Verification Program 2011
- Toggle 2 FDA Draft Guidance for Industry and FDA Staff Processing/Reprocessing Medical Devices in Health Care Settings Validation Methods and Labeling; Availability 2011
- Toggle 2 NHTSA Environmental Impact Statement for Corporate Average Fuel Economy (CAFE)Standards, Model Years 2017-2025 2011
- Toggle 1 NHTSA Feasibility of New Approaches for the Regulation of Motor Vehicle Lighting Performance 2011
- Toggle 1 OCC Volcker Rule - Prohibition on Proprietary Trading and Certain Relationships with Hedge Funds and Private Equity Funds 2011
- Toggle 1 FDA Amendments to Sterility Test Requirements for Biological Products 2011
- Toggle 1 USTR Request for comments on SPS Measures 2012
- Toggle 1 ITA Request for Public Comments Concerning Regulatory Cooperation Activities that Would Help Eliminate or Reduce Unnecessary Regulatory Divergences in North America that Disrupt U.S. Exports 2011
- Toggle 1 OSHA Review/Lookback of OSHA Chemical Standards 2012
- Toggle 1 OSHA Establishment of the Whistleblower Protection Advisory Committee (WPAC) 2012